Objective: To determine the effects on pain relief, function and quality of life in knee Osteoarthritis (OA) patients by a protocol of 3-doses of PRP injected weekly.
Material and methods:A prospective quasi-experimental before-and-after study (non-randomized control trial) was performed on 27 patients with knee OA Kellgren-Lawrence (K-L) grade 2 or more, from January 2014 to February 2017, referred to the Rehabilitation Department at Santa Cristina's University Hospital. The symptoms severity was evaluated using the Western Ontario and Mac Master Universities Index for Osteoarthritis (WOMAC). The PRP-protocol consisted of 3-sessions (1 session/ week) of an intra articular infiltration of 3ml of platelet-rich plasma (PRP). To get the PRP, Accelerate Concentration System Device® from EXACTECH, EmCyte Anticoagulant Sodium Citrate Solution U.S.P. and Drucker Centrifuge (Series Performance) were used.
Results:The mean age of the sample was 58.03±10.91 years. Before intervention, pain measured by VAS was 8.14±1.09 and decreased significantly to 2.96 (p=0.000) after treatment. Prior to treatment, WOMAC Pain Sub-scale was 14.88±7.02 and decreased to 5.55±6.87 points (p=0.000); WOMAC Stiffness sub-scale was 2.44±3.33 and diminished to 0.4±0.4 points (p=0.000); and WOMAC Function sub-scale was 44.48±12.27 and ameliorated to 15.25±12.38 points (p=0.000). As adverse effects, one patient presented important pain and inflammation after PRP infiltration (3.44%).
Conclusion:PRP Infiltrated in a 3-doses protocol is effective in the treatment of knee OA symptoms such as pain and stiffness, improving function and QoL. PRP alleviates knee OA symptoms in all radiological knee OA grades, even the most severe ones and with statistical difference.